A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, PK, and PD Effects of REGN2477-1033 in Obese Patients with Type 2 Diabetes Mellitus
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 3, 2018
End Date
May 12, 2020
Administered By
Duke Clinical Research Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 3, 2018
End Date
May 12, 2020